Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 83
Filter
1.
Talanta ; 270: 125600, 2024 Apr 01.
Article in English | MEDLINE | ID: mdl-38159349

ABSTRACT

We report a novel impedimetric sensor based on a graphite electrode impregnated with polyethylene and paraffin under vacuum (IGE) modified with electrochemically deposited gold and a self-assembled monolayer of N-acetyl-L-cysteine (NAC/Au/IGE) for selective and sensitive determination of extracellular hydroxyl radicals (OH•) generated by living cells. The application of a sulphur-containing molecule oxidized by OH• predicts the high selectivity of the sensor, and the utilization of the non-faradaic impedance spectroscopy for recording an analytical response makes it possible to achieve superior sensitivity with a detection limit of 0.01 nM and a linear dynamic range of 0.08-8 nM. Meanwhile, NAC/Au/IGE demonstrated a strong potential of detecting OH• generated by biological objects via successful determination of extracellular hydroxyl radicals generated by normal fibroblast cells and prostate carcinoma cells.


Subject(s)
Biosensing Techniques , Hydroxyl Radical , Acetylcysteine , Electrochemical Techniques/methods , Gold/chemistry , Electrodes , Cell Culture Techniques , Immunoglobulin E , Biosensing Techniques/methods , Limit of Detection
2.
Heliyon ; 9(11): e21003, 2023 Nov.
Article in English | MEDLINE | ID: mdl-37928038

ABSTRACT

The beneficial effects of caloric restriction (CR) and a ketogenic diet (KD) have been previously shown when performed prior to kidney injury. We investigated the effects of CR and KD on fibrosis development after unilateral kidney ischemia/reperfusion (UIR). Post-treatment with CR significantly (p < 0.05) affected blood glucose (2-fold decrease), ketone bodies (3-fold increase), lactate (1.5-fold decrease), and lipids (1.4-fold decrease). In the kidney, CR improved succinate dehydrogenase and malate dehydrogenase activity by 2-fold each, but worsened fibrosis progression. Similar results were shown for the KD, which restored the post-UIR impaired activities of succinate dehydrogenase, malate dehydrogenase, and α-ketoglutarate dehydrogenase (which was decreased 2-fold) but had no effect on fibrosis progression. Thus, our study shows that the use of CR or KD after UIR did not reduce the development of fibrosis, as shown by hydroxyproline content, western-blotting, and RT-PCR, whereas it caused significant metabolic changes in kidney tissue after UIR.

3.
Sci Rep ; 13(1): 12871, 2023 08 08.
Article in English | MEDLINE | ID: mdl-37553369

ABSTRACT

Fibrosis is a severe complication of chronic kidney disease (CKD). Progesterone, like other sex hormones, plays an important role in renal physiology, but its role in CKD is poorly understood. We investigated progesterone effect on renal fibrosis progression in the rat model of unilateral ureteral obstruction (UUO). Female rats were exposed to UUO, ovariectomy and progesterone administration after UUO with ovariectomy. Expression of key fibrosis markers, proinflammatory cytokines, levels of membrane-bound (PAQR5) and nuclear (PGR) progesterone receptors, and matrix metalloproteinase (MMP) activity were analyzed in the obstructed and intact rat kidney. In all groups exposed to UUO, decreased PAQR5 expression was observed in the obstructed kidney while in the contralateral kidney, it remained unaffected. We found increased mRNA levels for profibrotic COL1A1, FN1, MMP2, TIMP1, TIMP2, proinflammatory IL1α, IL1ß, and IL18, as well as elevated α-SMA and MMP9 proteins, collagen deposition, and MMP2 activity in all UUO kidneys. Progesterone had slight or no effect on the change in these markers. Thus, we demonstrate for the first time diminished sensitivity of the kidney to progesterone associated with renal fibrosis due to a severe decrease in PAQR5 expression that was accompanied by the lack of nephroprotection in a rat UUO model.


Subject(s)
Receptors, Progesterone , Renal Insufficiency, Chronic , Ureteral Obstruction , Animals , Female , Rats , Fibrosis , Kidney/metabolism , Matrix Metalloproteinase 2/metabolism , Progesterone/pharmacology , Renal Insufficiency, Chronic/complications , Ureteral Obstruction/complications , Ureteral Obstruction/drug therapy , Ureteral Obstruction/metabolism , Receptors, Progesterone/metabolism
4.
Bull Exp Biol Med ; 175(2): 245-248, 2023 Jun.
Article in English | MEDLINE | ID: mdl-37466855

ABSTRACT

Sequestosome-1 (SQSTM1/p62) is one of the most important multifunctional proteins, which is necessary to maintain mitochondrial stability by eliminating damaged mitochondria through mitophagy. We studied the influence of age and diet on the expression of the p62 gene in the femoral and abdominal muscles of rats, as well as the integrity of some mitochondrial components. In the femoral muscles of 24-month-old rats receiving restricted ration, the expression of the p62 gene increased. We assume that activation of mitophagy contributed to a decrease in the levels of oxidative damage to mitochondrial DNA and LPO intensity in the femoral muscles of 24-month-old rats.


Subject(s)
DNA, Mitochondrial , Mitochondria , Rats , Animals , DNA, Mitochondrial/genetics , DNA, Mitochondrial/metabolism , Lipid Peroxidation , Mitochondria/genetics , Mitochondria/metabolism , Muscle, Skeletal/metabolism , Gene Expression , Autophagy
5.
Sci Rep ; 12(1): 1710, 2022 02 02.
Article in English | MEDLINE | ID: mdl-35110605

ABSTRACT

The study is aimed at elucidating the effect of selenium nanoparticles (SeNPs) on the death of cells in the primary culture of mouse cerebral cortex during oxygen and glucose deprivation (OGD). A primary cell culture of the cerebral cortex containing neurons and astrocytes was subjected to OGD and reoxygenation to simulate cerebral ischemia-like conditions in vitro. To evaluate the neuroprotective effect of SeNPs, cortical astrocytes and neurons were incubated for 24 h with SeNPs, and then subjected to 2-h OGD, followed by 24-h reoxygenation. Vitality tests, fluorescence microscopy, and real-time PCR have shown that incubation of primary cultured neurons and astrocytes with SeNPs at concentrations of 2.5-10 µg/ml under physiological conditions has its own characteristics depending on the type of cells (astrocytes or neurons) and leads to a dose-dependent increase in apoptosis. At low concentration SeNPs (0.5 µg/ml), on the contrary, almost completely suppressed the processes of basic necrosis and apoptosis. Both high (5 µg/ml) and low (0.5 µg/ml) concentrations of SeNPs, added for 24 h to the cells of cerebral cortex, led to an increase in the expression level of genes Bcl-2, Bcl-xL, Socs3, while the expression of Bax was suppressed. Incubation of the cells with 0.5 µg/ml SeNPs led to a decrease in the expression of SelK and SelT. On the contrary, 5 µg/ml SeNPs caused an increase in the expression of SelK, SelN, SelT, SelP. In the ischemic model, after OGD/R, there was a significant death of brain cells by the type of necrosis and apoptosis. OGD/R also led to an increase in mRNA expression of the Bax, SelK, SelN, and SelT genes and suppression of the Bcl-2, Bcl-xL, Socs3, SelP genes. Pre-incubation of cell cultures with 0.5 and 2.5 µg/ml SeNPs led to almost complete inhibition of OGD/R-induced necrosis and greatly reduced apoptosis. Simultaneously with these processes we observed suppression of caspase-3 activation. We hypothesize that the mechanisms of the protective action of SeNPs involve the activation of signaling cascades recruiting nuclear factors Nrf2 and SOCS3/STAT3, as well as the activation of adaptive pathways of ESR signaling of stress arising during OGD and involving selenoproteins SelK and SelT, proteins of the Bcl-2 family ultimately leading to inactivation of caspase-3 and inhibition of apoptosis. Thus, our results demonstrate that SeNPs can act as neuroprotective agents in the treatment of ischemic brain injuries.


Subject(s)
Apoptosis/drug effects , Astrocytes/drug effects , Brain Ischemia/drug therapy , Cerebral Cortex/drug effects , Glucose/deficiency , Nanoparticles , Neurons/drug effects , Neuroprotective Agents/pharmacology , Selenium Compounds/pharmacology , Animals , Apoptosis Regulatory Proteins/genetics , Apoptosis Regulatory Proteins/metabolism , Astrocytes/metabolism , Astrocytes/pathology , Brain Ischemia/genetics , Brain Ischemia/metabolism , Brain Ischemia/pathology , Cell Hypoxia , Cells, Cultured , Cerebral Cortex/metabolism , Cerebral Cortex/pathology , Coculture Techniques , Female , Male , Mice , Necrosis , Neurons/metabolism , Neurons/pathology , Primary Cell Culture , Selenoproteins/genetics , Selenoproteins/metabolism
6.
Bull Exp Biol Med ; 171(5): 567-571, 2021 Sep.
Article in English | MEDLINE | ID: mdl-34617172

ABSTRACT

The phenomenon of ischemic preconditioning was discovered in 1986 in experiments with the heart, and then it was observed in almost all organs, the kidneys included. This phenomenon is underlain by conditioning of the tissues with short ischemia/reperfusion cycles intended for subsequent exposure to pathological ischemia. Despite the kidneys are not viewed as so vital organs as the brain or the heart, the acute ischemic injury to kidneys is a widespread pathology responsible for the yearly death of almost 2 million patients, while the number of patients with chronic kidney disease is estimated as hundreds of millions or nearly 10% adult population the world over. Currently, it is believed that adaptation of the kidneys to ischemia by preconditioning is the most effective way to prevent the development of acute kidney injury, so deep insight into its molecular mechanisms will be a launch pad for creating the nephroprotective therapy by elevating renal tolerance to oxygen deficiency. This review focuses on the key signaling pathways of kidney ischemic preconditioning, the potential pharmacological mimetics of its key elements, and the limitations of this therapeutic avenue associated with age-related decline of ischemic tolerance of the kidneys.


Subject(s)
Ischemic Preconditioning , Kidney/blood supply , Acute Kidney Injury/etiology , Acute Kidney Injury/prevention & control , Acute Kidney Injury/therapy , Adult , Animals , Humans , Hypoxia/etiology , Hypoxia/metabolism , Hypoxia/prevention & control , Hypoxia/therapy , Kidney/metabolism , Kidney/pathology , Reperfusion Injury/etiology , Reperfusion Injury/prevention & control , Reperfusion Injury/therapy
7.
Zh Nevrol Psikhiatr Im S S Korsakova ; 120(11): 108-115, 2020.
Article in Russian | MEDLINE | ID: mdl-33340305

ABSTRACT

However, despite successful use of lithium in the treatment of affective disorders for almost 40 years, the mechanisms of its therapeutic action are still poorly understood. This review presents and summarizes the current literature about the use of lithium in treatment of affective disorders, as well as its effects on cellular physiology, with a separate description of the effect of this ion on the functioning of nerve tissue and ion-molecular mechanisms.


Subject(s)
Bipolar Disorder , Psychopharmacology , Bipolar Disorder/drug therapy , Humans , Lithium/pharmacology , Lithium/therapeutic use , Mood Disorders/drug therapy
8.
Biosens Bioelectron ; 166: 112426, 2020 Oct 15.
Article in English | MEDLINE | ID: mdl-32750676

ABSTRACT

We present the first demonstration of bioelectrodes made from laser-reduced graphene oxide (rGO) on flexible polyethylene terephthalate (PET) substrates that overcome two main issues: using hydrogel on skin interface with standard Ag/AgCl bioelectrodes vs. low signal to noise ratio with capacitance or dry electrodes. Today we develop a dry rGO bioelectrode technology with long-term stability for 100 h in harsh environments and when in contact with skin. Reliability tests in different buffer solutions with pH from 4.8 to 9.2 tested over 24 h showed the robustness of rGO electrodes. In terms of signal to noise ratio, our bioelectrodes performance is comparable to that of commercial ones. The bioelectrodes demonstrate an excellent signal to noise ratio, with a signal match of over 98% with respect to state-of-the-art electrodes used as a benchmark. We attribute the unique stability of our bioelectrodes to the rGO/PET interface modification and composite formation during laser processing used for GO reduction. The rGO/PET composite formation assertion is confirmed by mechanical stripping experiments and visual examination of re-exposed PET. The method developed here is simple, cost-effective, maskless, and can be scaled-up, allowing sustainable manufacture of arbitrary-shaped flexible electrodes for biomedical sensors and wearables.


Subject(s)
Biosensing Techniques , Graphite , Electrodes , Reproducibility of Results , Water
9.
Bull Exp Biol Med ; 169(2): 213-217, 2020 Jun.
Article in English | MEDLINE | ID: mdl-32651821

ABSTRACT

We studied the development of acute kidney injury and animal death in the model of combined injury caused by kidney ischemia/reperfusion with simultaneous systemic administration of mitochondria. It was found that intraperitoneal injection of isolated mitochondria led to the appearance of mitochondrial DNA in the peripheral blood that could activate innate immunity. After administration of mitochondria, as well as after renal ischemia/reperfusion, proinflammatory changes were observed, primarily leukocytosis and granulocytosis. The combination of ischemia/reperfusion with injection of mitochondria caused a sharp increase in animal death, which may indicate a direct link between activation of TLR-signaling and high mortality of patients with combined injuries and multiple-organ failure in intensive care units. Treatment with mitochondria-targeted antioxidant increased animal survival, which indicated the participation of mitochondrial ROS in the development of systemic inflammatory response and death caused by acute renal failure.


Subject(s)
Inflammation/metabolism , Kidney/metabolism , Mitochondria/metabolism , Reperfusion Injury/metabolism , Animals , Antioxidants/metabolism , DNA, Mitochondrial/metabolism , Leukocytosis/metabolism , Male , Oxidative Stress/physiology , Rats , Sepsis/metabolism , Shock/metabolism
10.
Zh Nevrol Psikhiatr Im S S Korsakova ; 120(3. Vyp. 2): 29-32, 2020.
Article in Russian | MEDLINE | ID: mdl-32307427

ABSTRACT

INTRODUCTION: Ischemic stroke is one of the most severe neurological pathologies with high mortality and disability. In this connection, the development and study of new drugs for the prevention and treatment of stroke is an extremely important task. A new approach to neuroprotection is the use of lithium salts with antioxidant activity. AIM: To study the cerebroprotective effect of lithium ascorbate on a rat model of ischemic stroke. MATERIAL AND METHODS: Test samples of lithium ascorbate were synthesized ex tempore for an experiment using reagents of ACS qualification (Sigma-Aldrich). The ischemic stroke model was realized using the filament occlusion of the middle cerebral artery in rats of the Sprague Dawley line according to standardized procedure. Neurological examination of the animals, histological study of brain tissue with staining of brain sections, and calculating the volume of cerebral infarction were performed. RESULTS AND CONCLUSION: There is a significant cerebroprotective effect of lithium ascorbate expressed in a multiple decrease in the volume of the zone of cerebral infarction (by 75% of the control group indicator) and the absence of mortality in the experimental group of animals. Newly discovered distinct anti-stroke effect of lithium ascorbate in combination with low toxicity could be considered promising for further clinical studies and practical application in neurology.


Subject(s)
Brain Ischemia/drug therapy , Brain Ischemia/prevention & control , Disease Models, Animal , Lithium Compounds/therapeutic use , Neuroprotective Agents/therapeutic use , Stroke/drug therapy , Stroke/prevention & control , Animals , Brain Ischemia/pathology , Cerebral Infarction/drug therapy , Cerebral Infarction/pathology , Lithium Compounds/pharmacology , Neuroprotective Agents/pharmacology , Rats , Rats, Sprague-Dawley , Stroke/pathology
11.
Biochemistry (Mosc) ; 85(12): 1570-1577, 2020 Dec.
Article in English | MEDLINE | ID: mdl-33705295

ABSTRACT

The mechanism of oxidative phosphorylation and its regulation remain one of the main problems of bioenergetics. Efficiency of the mitochondrial energization is determined by the relationship between the rate of generation of electrochemical potential of hydrogen ions and the rate of its expenditure on the synthesis of ATP and the use of ATP in endergonic reactions. Uncoupling (partial or complete), which occurs in the process of uncontrolled and controlled leakage of ions through the inner mitochondrial membrane, on the one hand leads to the decrease in the relative synthesis of ATP, and on the other, being consistent with the law of conservation of energy, leads to the formation of heat, generation of which is an essential function of the organism. In addition to increased thermogenesis, the increase of non-phosphorylating oxidation of various substrates is accompanied by the decrease in transmembrane potential, production of reactive oxygen species, and activation of oxygen consumption, water and carbon dioxide production, increase in the level of intracellular ADP and acidification of the cytosol. In this analysis, each of these factors will be considered separately for its role in regulating metabolism.


Subject(s)
Energy Metabolism , Mitochondria/metabolism , Thermogenesis , Animals , Humans , Mitochondria/physiology
12.
Biochemistry (Mosc) ; 85(12): 1578-1590, 2020 Dec.
Article in English | MEDLINE | ID: mdl-33705296

ABSTRACT

Appending lipophilic cations to small molecules has been widely used to produce mitochondria-targeted compounds with specific activities. In this work, we obtained a series of derivatives of the well-known fluorescent dye 7-nitrobenzo-2-oxa-1,3-diazole (NBD). According to the previous data [Denisov et al. (2014) Bioelectrochemistry, 98, 30-38], alkyl derivatives of NBD can uncouple isolated mitochondria at concentration of tens of micromoles despite a high pKa value (~11) of the dissociating group. Here, a number of triphenylphosphonium (TPP) derivatives linked to NBD via hydrocarbon spacers of varying length (C5, C8, C10, and C12) were synthesized (mitoNBD analogues), which accumulated in the mitochondria in an energy-dependent manner. NBD-C10-TPP (C10-mitoNBD) acted as a protonophore in artificial lipid membranes (liposomes) and uncoupled isolated mitochondria at micromolar concentrations, while the derivative with a shorter linker (NBD-C5-TPP, or C5-mitoNBD) exhibited no such activities. In accordance with this data, C10-mitoNBD was significantly more efficient than C5-mitoNBD in suppressing the growth of Bacillus subtilis. C10-mitoNBD and C12-mitoNBD demonstrated the highest antibacterial activity among the investigated analogues. C10-mitoNBD also exhibited the neuroprotective effect in the rat model of traumatic brain injury.


Subject(s)
Anti-Bacterial Agents/pharmacology , Brain Injuries/prevention & control , Mitochondria, Liver/drug effects , Neuroprotective Agents/pharmacology , Nitrobenzenes/pharmacology , Organophosphorus Compounds/pharmacology , Oxadiazoles/pharmacology , Animals , Bacillus subtilis/drug effects , Disease Models, Animal , Energy Metabolism , Mitochondria, Liver/metabolism , Nitrobenzenes/chemistry , Organophosphorus Compounds/chemistry , Oxadiazoles/chemistry , Rats , Thermogenesis
13.
Biochemistry (Mosc) ; 85(12): 1591-1602, 2020 Dec.
Article in English | MEDLINE | ID: mdl-33705297

ABSTRACT

Inflammation and oxidative stress are the main pathological processes that accompany ischemic injury of kidneys and other organs. Based on this, these factors are often chosen as a target for treatment of acute kidney injury (AKI) in a variety of experimental and clinical studies. Note, that since these two components are closely interrelated during AKI development, substances that treat one of the processes often affect the other. The review considers several groups of promising nephroprotectors that have both anti-inflammatory and antioxidant effects. For example, many antioxidants, such as vitamins, polyphenolic compounds, and mitochondria-targeted antioxidants, not only reduce production of the reactive oxygen species in the cell but also modulate activity of the immune cells. On the other hand, immunosuppressors and non-steroidal anti-inflammatory drugs that primarily affect inflammation also reduce oxidative stress under some conditions. Another group of therapeutics is represented by hormones, such as estrogens and melatonin, which significantly reduce severity of the kidney damage through modulation of both these processes. We conclude that drugs with combined anti-inflammatory and antioxidant capacities are the most promising agents for the treatment of acute ischemic kidney injury.


Subject(s)
Acute Kidney Injury/drug therapy , Anti-Inflammatory Agents/pharmacology , Antioxidants/pharmacology , Inflammation/drug therapy , Oxidative Stress/drug effects , Acute Kidney Injury/metabolism , Acute Kidney Injury/pathology , Animals , Anti-Inflammatory Agents/therapeutic use , Antioxidants/therapeutic use , Humans , Ischemia
14.
Biochemistry (Mosc) ; 84(12): 1502-1512, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31870254

ABSTRACT

Autophagy plays an important role in the pathogenesis of acute kidney injury (AKI). Although autophagy activation was shown to be associated with an increased lifespan and beneficial effects in various pathologies, the impact of autophagy activators, particularly, rapamycin and its analogues on AKI remains obscure. In our study, we explored the effects of rapamycin treatment in in vivo and in vitro models of ischemic and cisplatin-induced AKI. The impact of rapamycin on the kidney function after renal ischemia/reperfusion (I/R) or exposure to the nephrotoxic agent cisplatin was assessed by quantifying blood urea nitrogen and serum creatinine and evaluating the content of neutrophil gelatinase-associated lipocalin, a novel biomarker of AKI. In vitro experiments were performed on the primary culture of renal tubular cells (RTCs) that were subjected to oxygen-glucose deprivation (OGD) or incubated with cisplatin under various rapamycin treatment protocols. Cell viability and proliferation were estimated by the MTT assay and real-time cell analysis using an RTCA iCELLigence system. Although rapamycin inhibited mTOR (mammalian target of rapamycin) signaling, it failed to enhance the autophagy and to ameliorate the severity of AKI caused by ischemia or cisplatin-induced nephrotoxicity. Experiments with RTCs demonstrated that rapamycin exhibited the anti-proliferative effect in primary RTCs cultures but did not protect renal cells exposed to OGD or cisplatin. Our study revealed for the first time that the mTOR inhibitor rapamycin did not prevent AKI caused by renal I/R or cisplatin-induced nephrotoxicity and, therefore, cannot be considered as an ideal mimetic of the autophagy-associated nephroprotective mechanisms (e.g., those induced by caloric restriction), as it had been suggested earlier. The protective action of such approaches like caloric restriction might not be limited to mTOR inhibition and can proceed through more complex mechanisms involving alternative autophagy-related targets. Thus, the use of rapamycin and its analogues for the treatment of various AKI forms requires further studies in order to understand potential protective or adverse effects of these compounds in different contexts.


Subject(s)
Acute Kidney Injury/chemically induced , Acute Kidney Injury/prevention & control , Antineoplastic Agents/adverse effects , Cisplatin/adverse effects , Ischemia/prevention & control , Sirolimus/pharmacology , Acute Kidney Injury/metabolism , Animals , Cells, Cultured , Glucose/metabolism , Ischemia/metabolism , Kidney Tubules/drug effects , Kidney Tubules/metabolism , Male , Oxygen/metabolism , Protective Agents/pharmacology , Rats , TOR Serine-Threonine Kinases/metabolism
15.
Biomed Khim ; 65(1): 28-32, 2019 Jan.
Article in Russian | MEDLINE | ID: mdl-30816094

ABSTRACT

Organic lithium salts containing anionic components (succinate, fumarate, pyruvate and antioxidant ascorbate) were tested for protection of blood plasma proteins and lipids against ethanol-induced oxidation in vitro. We used normothymic lithium carbonate and well-known antioxidant dipeptide carnosine (b-alanyl-L-histidine) as the reference drugs. The oxidized proteins and lipids were determined by the level of carbonylated proteins (CP) and TBA-reactive products (TBA-RP), respectively. In alcoholic patients the level of oxidized proteins and lipids was higher than in healthy persons. Incubation of blood with ethanol resulted in an increase in oxidized proteins and lipids in blood plasma of healthy persons but had no influence on the level of CP and TBA-RP in blood plasma of alcoholic patients. Lithium carbonate, lithium ascorbate, and lithium succinate exhibited protective action against ethanol-induced oxidation of biomolecules of blood plasma of healthy people. These effects were comparable with carnosine action. The studied compounds had no effect on the level of CP and TBA-RP of blood plasma of alcoholic patients.


Subject(s)
Alcoholism , Carnosine/therapeutic use , Ethanol/toxicity , Lithium/therapeutic use , Oxidative Stress/drug effects , Antioxidants , Blood Proteins/chemistry , Humans , Lipids/blood , Protein Carbonylation , Salts
16.
Bull Exp Biol Med ; 166(3): 334-338, 2019 Jan.
Article in English | MEDLINE | ID: mdl-30627903

ABSTRACT

Activities of MMP-2 and MMP-9 in the cytoplasm and mitochondria of kidney cells were evaluated on the models of acute renal pathologies: pyelonephritis, rhabdomyolysis, and ischemia/reperfusion of the kidney. In acute pyelonephritis, a significant increase in the level of MMP-2 and MMP-9 in kidney cells and the appearance of mitochondrial MMP-2 isoform with a lower molecular weight, but still exhibiting proteolytic activity were observed. A direct correlation between the level of MMP-2 and MMP-9 in the kidney and the severity of inflammation in pyelonephritis was revealed. Obviously, the appearance of active protease in the mitochondria of the kidney cells could have an impact on their functioning and, generally, on the fate of renal cells in this pathology.


Subject(s)
Bacterial Infections/genetics , Matrix Metalloproteinase 2/genetics , Matrix Metalloproteinase 9/genetics , Mitochondria/genetics , Pyelonephritis/genetics , Reperfusion Injury/genetics , Rhabdomyolysis/genetics , Acute Disease , Animals , Animals, Outbred Strains , Bacterial Infections/enzymology , Bacterial Infections/pathology , Disease Models, Animal , Epithelial Cells , Gene Expression Regulation , Isoenzymes/genetics , Isoenzymes/metabolism , Kidney/enzymology , Kidney/pathology , Kidney/surgery , Matrix Metalloproteinase 2/metabolism , Matrix Metalloproteinase 9/metabolism , Mitochondria/enzymology , Mitochondria/pathology , Nephrectomy/methods , Pyelonephritis/enzymology , Pyelonephritis/pathology , Rats , Reperfusion Injury/enzymology , Reperfusion Injury/pathology , Rhabdomyolysis/enzymology , Rhabdomyolysis/pathology , Severity of Illness Index
17.
Neurochem Res ; 44(10): 2261-2272, 2019 Oct.
Article in English | MEDLINE | ID: mdl-30519983

ABSTRACT

Traumatic brain injury is one of the leading causes of disability among the working-age population worldwide. Despite attempts to develop neuroprotective therapeutic approaches, including pharmacological or cellular technologies, significant advances in brain regeneration have not yet been achieved. Development of silk fibroin-based biomaterials represents a new frontier in neuroregenerative therapies after brain injury. In this study, we estimated the short and long-term effects of silk fibroin scaffold transplantation on traumatic brain injury and biocompatibility of this biomaterial within rat neuro-vascular cells. Silk fibroin microparticles were injected into a brain damage area 1 day after the injury. Silk fibroin affords neuroprotection as judged by diminished brain damage and recovery of long-term neurological functions. We did not detect considerable toxicity to neuro-vascular cells cultured on fibroin/fibroin-gelatin microparticles in vitro. Cultivation of primary cell cultures of neurons and astrocytes on silk fibroin matrices demonstrated their higher viability under oxygen-glucose deprivation compared to 2D conditions on plastic plates. Thus, we conclude that scaffolds based on silk fibroin can become the basis for the creation of constructs aimed to treat brain regeneration after injury.


Subject(s)
Brain Injuries, Traumatic/drug therapy , Cell Proliferation/drug effects , Fibroins/pharmacology , Nerve Regeneration/drug effects , Animals , Biocompatible Materials/analysis , Cells, Cultured , Disease Models, Animal , Fibroins/ultrastructure , Rats , Tissue Scaffolds
18.
Bull Exp Biol Med ; 165(2): 189-194, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29923010

ABSTRACT

Oxidative kidney injury was compared in newborn and adult rats under conditions of ischemia/reperfusion and in experimental model of systemic inflammation induced by endotoxin (LPS of bacterial cell wall) administration. Oxidative stress in the kidney accompanied both experimental models, but despite similar oxidative tissue damage, kidney dysfunction in neonates was less pronounced than in adult animals. It was found that neonatal kidney has a more potent regenerative potential with higher level of cell proliferation than adult kidney, where the level proliferating cell antigen (PCNA) increased only on day 2 after ischemia/reperfusion. The pathological process in the neonatal kidney developed against the background of active cell proliferation, and, as a result, proliferating cells could almost immediately replace the damaged structures. In the adult kidney, regeneration of the renal tissue was activated only after significant loss of functional nephrons and impairment of renal function.


Subject(s)
Acute Kidney Injury/chemically induced , Aging/pathology , Endotoxins/adverse effects , Ischemia/chemically induced , Reperfusion Injury/chemically induced , Acute Kidney Injury/pathology , Acute Kidney Injury/physiopathology , Age Factors , Animals , Animals, Newborn , Female , Ischemia/complications , Ischemia/pathology , Ischemia/physiopathology , Kidney/cytology , Kidney/pathology , Kidney/physiology , Male , Rats , Regeneration/physiology , Reperfusion Injury/complications , Reperfusion Injury/pathology , Reperfusion Injury/physiopathology , Severity of Illness Index
19.
Biochemistry (Mosc) ; 82(9): 1006-1016, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28988529

ABSTRACT

Remote ischemic preconditioning of hind limbs (RIPC) is an effective method for preventing brain injury resulting from ischemia. However, in numerous studies RIPC has been used on the background of administered anesthetics, which also could exhibit neuroprotective properties. Therefore, investigation of the signaling pathways triggered by RIPC and the effect of anesthetics is important. In this study, we explored the effect of anesthetics (chloral hydrate and Zoletil) on the ability of RIPC to protect the brain from injury caused by ischemia and reperfusion. We found that RIPC without anesthesia resulted in statistically significant decrease in neurological deficit 24 h after ischemia, but did not affect the volume of brain injury. Administration of chloral hydrate or Zoletil one day prior to brain ischemia produced a preconditioning effect by their own, decreasing the degree of neurological deficit and lowering the volume of infarct with the use of Zoletil. The protective effects observed after RIPC with chloral hydrate or Zoletil were similar to those observed when only the respective anesthetic was used. RIPC was accompanied by significant increase in the level of brain proteins associated with the induction of ischemic tolerance such as pGSK-3ß, BDNF, and HSP70. However, Zoletil did not affect the level of these proteins 24 h after injection, and chloral hydrate caused increase of only pGSK-3ß. We conclude that RIPC, chloral hydrate, and Zoletil produce a significant neuroprotective effect, but the simultaneous use of anesthetics with RIPC does not enhance the degree of neuroprotection.


Subject(s)
Anesthetics/therapeutic use , Brain Injuries/etiology , Brain Ischemia/complications , Ischemic Preconditioning , Neuroprotective Agents/therapeutic use , Anesthetics/pharmacology , Animals , Brain Injuries/prevention & control , Brain Ischemia/drug therapy , Brain Ischemia/therapy , Chloral Hydrate/pharmacology , Chloral Hydrate/therapeutic use , Drug Combinations , Male , Neuroprotective Agents/pharmacology , Rats , Tiletamine/pharmacology , Tiletamine/therapeutic use , Treatment Outcome , Zolazepam/pharmacology , Zolazepam/therapeutic use
20.
Bull Exp Biol Med ; 163(4): 528-534, 2017 Aug.
Article in English | MEDLINE | ID: mdl-28853074

ABSTRACT

We studied the neuroprotective potential of multipotent mesenchymal stromal cells in traumatic brain injury and the effect of inflammatory preconditioning on neuroprotective properties of stem cells under in vitro conditions. To this end, the effects of cell incubation with LPS or their co-culturing with leukocytes on production of cytokines IL-1α, IL-6, TNFα, and MMP-2 and MMP-9 by these cells were evaluated. Culturing under conditions simulating inflammation increased the production of all these factors by multipotent mesenchymal stromal cells. However, acquisition of the inflammatory phenotype by stromal cells did not reduce their therapeutic effectiveness in traumatic brain injury. Moreover, in some variants of inflammatory preconditioning, multipotent mesenchymal stromal cells exhibited more pronounced neuroprotective properties reducing the volume of brain lesion and promoting recovery of neurological functions after traumatic brain injury.


Subject(s)
Brain Injuries/metabolism , Cytokines/metabolism , Inflammation/metabolism , Mesenchymal Stem Cells/metabolism , Animals , Brain Injuries/pathology , Cells, Cultured , Interleukin-1alpha/metabolism , Interleukin-6/metabolism , Magnetic Resonance Imaging , Male , Matrix Metalloproteinase 2/metabolism , Matrix Metalloproteinase 9/metabolism , Rats , Tumor Necrosis Factor-alpha/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...